AI assistant
Sending…
Merck & Co., Inc. — Director's Dealing 2017
Apr 10, 2017
284_dirs_2017-04-10_58d96186-f4a2-43d7-aad3-35232d454206.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2017-02-27
Reporting Person: Holston Michael J (EVP, General Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-02-27 | Common Stock | A | 11312.0000 | $65.8500 | Acquired | 61592.2270 | Direct |
Footnotes
F1: The Amended Form 4 is being filed to correct an administrative error with regard to the number of shares withheld for payment of taxes on the 2/27/17 vesting of performance share units. The number of securities beneficially owned following the reported transaction should have been reported as 61,592.2270, and includes shares acquired in dividend reinvestment transactions.
More from Merck & Co., Inc.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 4
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 30
Annual Report
2026
Apr 8
Proxy Solicitation & Information Statement
2026
Apr 8